LOX and breast carcinoma: Finally, using an orthotopic 4T1-BALB/c model of bone-metastatic mammary carcinoma, Cox et al. showed that LOX stimulates the formation of osteolytic lesions, a major contributor to breast cancer patient morbidity and mortality, by enhancing both osteoblast differentiation and osteoclast activity [148].